Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,533.00p
   
  • Change Today:
      7.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,507.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 90,999
  • Market Cap: £3,401.52m
  • RiskGrade: 125
  • Beta: 0.95

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,533.00p
Change Today 7.00p
% Change 0.46 %
52 Week High 2,340.00
52 Week Low 1,507.00
Volume 90,999
Shares Issued 221.89m
Market Cap £3,401.52m
Beta 0.95
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income
38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

What The Brokers Say

Strong Buy 7
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 14-Aug-25 20-Mar-25
Paid 18-Sep-25 01-May-25
Amount 36.00¢ 48.00¢

Trades for 24-Dec-2025

Time Volume / Share Price
12:35 57,422 @ 1,533.00p
12:35 300 @ 1,533.00p
12:35 43 @ 1,533.00p
12:35 318 @ 1,533.00p
12:35 256 @ 1,533.00p

Top of Page